Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: ACOD1 as a Prognostic Marker for Sepsis

View source ↗

Summary

A clinical trial is evaluating ACOD1 as a prognostic biomarker for sepsis and is currently recruiting at Union Hospital, Tongji Medical College (Huazhong Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Sepsis | Status: RECRUITING